Sun Pharmaceutical’s consolidated net profit rose 6.94% YoY to Rs.1,309 crore, in the quarter ended March 31,2018.
The company’s consolidated revenue for the quarter under review dropped 1.11% YoY to Rs.7,279.9 crore. Consolidated earnings before interest, tax, depreciation and amortization (EBITDA) margin stood at 24.1%, for the quarter under review.
The operating income rose 8.8% on a yearly basis to Rs.1,683.5 crore, and operating margin contracted to 24.1%, from 24.8%. Further, the company declared a dividend of Rs.2 per equity share of Re.1